Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.

Saved in:
Bibliographic Details
Title: Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
Authors: De Kort AM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands., Kuiperij HB; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands., Marques TM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands., Jäkel L; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands., van den Berg E; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands., Kersten I; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands., van Berckel-Smit HEP; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands., Duering M; Medical Image Analysis Center and Qbig, Department of Biomedical Engineering, University of Basel, Basel, Switzerland., Stoops E; ADx NeuroSciences, Ghent, Belgium., Abdo WF; Department of Intensive Care, Radboud University Medical Center, Nijmegen, the Netherlands., Rasing I; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Voigt S; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Koemans EA; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Kaushik K; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Warren AD; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Greenberg SM; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Brinkmalm G; Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, and Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden., Terwindt GM; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Wermer MJH; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Schreuder FHBM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands., Klijn CJM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands., Verbeek MM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands.; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Source: Annals of neurology [Ann Neurol] 2023 Jun; Vol. 93 (6), pp. 1173-1186. Date of Electronic Publication: 2023 Feb 20.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8249 (Electronic) Linking ISSN: 03645134 NLM ISO Abbreviation: Ann Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1531-8249
DOI:10.1002/ana.26610